| 690 | 11 | 25 |
| 下载次数 | 被引频次 | 阅读次数 |
目的建立和验证人肝微粒体中CYP3A4探药代谢物6β-羟基睾酮和1-羟基咪达唑仑的测定方法 ,以准确体外评价CYP3A4的活性。方法在人肝微粒体温孵系统中加入睾酮37℃温孵生成6β-羟基睾酮,经过碱化后用乙酸乙酯提取微粒体样本,采用Phenomenex Gemina C18分离,流动相由甲醇和水组成,梯度洗脱,流速1.0 mL·min-1,检测波长245 hm,测定微粒体中6β-羟基睾酮浓度;或人肝微粒体温孵系统中加入咪达唑仑,37℃温孵生成1-羟基咪达唑仑,经过乙腈处理人肝微粒体样本,采用Diamosil C18分离,20 mmoL·L-1醋酸铵-乙腈(60:40,V/V)流动相等度洗脱,流速1.0mL·min-1,检测波长254 nm,测定1-羟基咪达唑仑浓度。结果 6β-羟基睾酮线性范围为0.111~8.90 mg·L-1,1-羟基咪达唑仑线性范围为20~1 000 mg·L-1,两代谢物的批内、批间差异<15%,准确度为85%~115%。结论建立的测定微粒体中6β-羟基睾酮和1-羟基咪达唑仑浓度的方法符合生物样品测定的要求,能准确测定微粒体中目标物浓度,可用于评价CYP3A4的活性。
Abstract:AIM To establish and validate the HPLC methods of determining the concentrations of 6β-hydroxytestosterone and 1-hydroxymidazolam in human liver microsomes to accurately evaluate the activity of CYP3A4 in vitro. METHODS For 6β-hydroxytestosterone,after incubation with testosterone in the microsome system at 37℃,the samples containing 6β-hydroxytestosterone were extracted with ethyl acetate after being basified.Separation was achieved using a Phenomenex Gemina C18 column and a gradient mobile phase of methanol and water at a flow rate of 1 mL·min-1.The concentrations of 6β-hydroxytestosterone were determined using a UV detector set at a wavelength of 245 nm.For 1-hydroxymidazolam, after incubation with midazolam in the microsome system at 37℃,the samples containing 1-hydroxymidazolam were extracted using a protein precipitation with acetonitrile.Separation was achieved on a Diamosil C18 column with isocratic mobile phase of 20 mmol·L-1 ammonium acetate-acetonitrile(60:40,V/V) at a flow rate of 1.0 mL·min-1,The concentrations of 1-hydroxymidazolam were determined using a UV detector set at a wavelength of 254 nm. RESULTS The linearity ranges of 6β-hydroxytestosterone and 1-hydroxymidazolam were 0.111-8.90 mg·L-1 and 20-1 000μg·L-1,respectively.RSD of intra- and inter- batches for both metabolites were below 15%and accuracies were within 85%-115%.CONCLUSION The methods for the quantification of 6β-hydroxytestosterone and 1-hydroxymidazolam in human liver microsomes meet the requirements for biological sample determination,and are able to be applied in the evaluation of the activity of CYP3A4 in vitro.
[1]Bjomsson TD.Callaghan JT,Einolf HJ,et al.The conduct of in vitro and in vivo drug-drug interaction studies:a PhRMA perspective[J].J Clin Pharmacol,2003,43(5):443.
[2]张荣,刘昌辉,王宁生,等.以睾酮为探针采用高效液相色谱法测定细胞色素CYP450 3A4的酶活性[J].色谱,2008,26(1):80.
[3]Wang D,Zhang M.Rapid quantitation of testosterone hydroxyl metabolites by ultra-performance liquid chromatography and mass spectrometry [J].J Chromatogr B,2007,855(2):290.
[4]Shimizu M,Uno T,Tamura HO,et al.A developed determination of midazolam and 1 '-hydroxymidazolam in human liver microsomes by liquid chromatography-mass spectrometry:application of human pharmacokinetic study for measurement of CYP3A activity[J].J Chromatogr B Analyt Technol Biomed Life Sci,2007,847(2):275.
[5]Jabor VA,Coelho EB,Dos Santos NA,et al.A highly sensitive LCMS -MS assay for analysis of midazolam and its major metabolite in human plasma:applications to drug metabolism[J].J Chromatogr B Analyt Technol Biomed Life Sci,2005,822(1-2):27.
[6]Yao M,Zhu MS,Sinz MW,et al.Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC-MS/MS analysis[J].J Pharma Biomed Anal,2007,44(1):211.
基本信息:
DOI:10.19577/j.cnki.issn10074406.2010.03.003
中图分类号:R96
引用信息:
[1]裘福荣,张荣,孙建国,等.HPLC法测定人肝微粒体6β-羟基睾酮和1-羟基咪达唑仑浓度[J].中国临床药学杂志,2010,19(03):145-148.DOI:10.19577/j.cnki.issn10074406.2010.03.003.
基金信息:
上海卫生局局级课题(编号049); 国家自然科研基金(编号30630076); 上海市教委重点学科中药临床药理学(编号J50303); 临床药理学科研共享平台(编号SHDC12007202)
2010-05-25
2010-05-25